Results 111 to 120 of about 17,391 (234)

Are we prematurely predicting acute mountain sickness?

Experimental Physiology, EarlyView.
Julian C. Bommarito, Michael M. Tymko
wiley   +1 more source

Lymphoid Interstitial Pneumonia Without Known Cause: Diagnostic Work Up and Differential Considerations

Respirology Case Reports, Volume 13, Issue 4, April 2025.
We present a case of diffuse cystic lung disease without any known underlying systemic disorder, biopsy confirmed as lymphoid interstitial pneumonia (LIP). This case highlights the benefit of histological confirmation where there is diagnostic uncertainty and the clinical situation permits, particularly in the setting of symptomatic deterioration ...
Han Xin Lau, Liam Krebs, Sarah Sim, Taryn Reddy   +3 more
wiley   +1 more source

The Omics Landscape of Long COVID—A Comprehensive Systematic Review to Advance Biomarker, Target and Drug Discovery

Allergy, Volume 80, Issue 4, Page 932-948, April 2025.
ABSTRACT An estimated 10% of coronavirus disease (COVID‐19) survivors suffer from persisting symptoms referred to as long COVID (LC), a condition for which approved treatment options are still lacking. This systematic review (PROSPERO: CRD42024499281) aimed to explore the pathophysiological mechanisms underlying LC and potential treatable traits across
Nadia Baalbaki, Elise M. A. Slob, Samuel W. Kazer, Mahmoud I Abdel‐Aziz, Harm Jan Bogaard, Korneliusz Golebski, Anke H. Maitland‐van der Zee   +6 more
wiley   +1 more source

Immunological Features and Potential Biomarkers of Systemic Sclerosis–Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis

The Clinical Respiratory Journal, Volume 19, Issue 4, April 2025.
The results revealed that the CD4+/CD8+ T cell ratio of pbmc in SSc‐ILD patients was significantly higher than in SSc‐nonILD patients. In IPF patients, an elevated CD4+/CD8+ T cell ratio was also observed in progressive group, and Treg and mature CD4 + T cells might cause this change.
Shuai Shao, Siyu Cao, Yusha Chen, Zhijin Zhang, Tong Zhaohui   +4 more
wiley   +1 more source

Widening Patient Engagement for Rare Disease Drug Trials: The Perspectives of Patients With Idiopathic Pulmonary Fibrosis on Participating in Clinical Drug Trials and Drug Trial Design

Health Expectations, Volume 28, Issue 2, April 2025.
ABSTRACT Background Research about patient engagement for people with rare diseases has identified how the experiences of some members of the public are overlooked in relation to clinical trial design and trial participation. As part of a knowledge transfer partnership (KTP), the authors were granted access to patient insight reports about the needs of
Julia Frost, Widening Engagement Patient Advisory Group, Jessica Mandizha, Steve Jones, Chantal van den Dungen, Lauren Asare, Catherine Pope   +6 more
wiley   +1 more source

Two is better than one: the double diffusion technique in classifying heart failure

ERJ Open Research
Background Heart failure (HF) is a chronic condition in which the heart does not pump enough blood to meet the body's demands. Diffusing capacity of the lung for nitric oxide (DLNO) and carbon monoxide (DLCO) may be used to classify patients with HF, as ...
Gerald S. Zavorsky, Piergiuseppe Agostoni   +1 more
doaj   +1 more source

Measuring lung mechanics in patients with COPD using the handheld portable rapid expiratory occlusion monitor (REOM): A cross‐sectional study

Physiological Reports, Volume 13, Issue 7, April 2025.
Abstract While conventional spirometry is associated with strenuous “forced” maximal respiratory maneuvers and infection control implications, oscillometry is not associated with these issues. However, portability, convenience of use, and interpretation remain common limitations to both techniques.
Felix‐Antoine Coutu, Dany Malaeb, Olivia C. Iorio, Seyedfakhreddin Nabavi, Tom McFarland, Lennart K. A. Lundblad, Ron J. Dandurand, Stewart B. Gottfried, Bryan A. Ross   +8 more
wiley   +1 more source

The cluster-specific mean physiologic measures (FEV1/FVC ratio, percentage predicted values of DLCO, TLC, FEV1, and FVC) for the ten stratified groups.

, 2014
Raghunath Sushravya, Rajagopalan Srinivasan, Arya Ronald, Maldonado Fabien, Peikert Tobias, Teng Moua, Hollman Jay, J. Bartholmai Brian, Adélaïde Richard   +8 more
openalex   +1 more source

Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline

, 2016
Michele Colaci, D. Giuggioli, Marco Sebastiani, Andreina Manfredi, Federica Lumetti, Fabrizio Luppi, Stefania Cerri, Claudio Ferri   +7 more
openalex   +2 more sources

Prognostic Marker for Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Analysis of Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) and Forced Expiratory Volume in One Second (FEV1) [PDF]

, 2020
Juwhan Choi, Jae Kyeom Sim, Jee Youn Oh, Young Seok Lee, Gyu Young Hur, Sung Yong Lee, Jae Jeong Shim, Chin Kook Rhee, Kyung Hoon Min   +8 more
openalex   +1 more source